Expression of vascular endothelial growth factor in thoracic sarcomas

Annals of Thoracic Surgery

Volumn 71, Issue 5, 2001, Pages 1635-1639

  Iyoda, Akira ^a   Hiroshima, Kenzo ^a   Baba, Masayuki ^a   Fujisawa, Takehiko ^a   Yusa, Toshikazu ^b   Ohwada, Hidemi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CARCINOMA; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SARCOMA; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SARCOMA; THORACIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035019352     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02533-4     Document Type: Article

References (20)

1. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1995;1029-1039.
2. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
3. Angelov L., Salhia B., Roncari L., McMahon G., Guha A. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas. Cancer Res. 59:1999;5536-5541.
4. Brown L.F., Berse B., Jackman R.W., et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol. 143:1993;1255-1262.
5. Brown L.F., Berse B., Jackman R.W., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53:1993;4727-4735.
6. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845-848.
7. Volm M., Koomagi R., Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer. 74:1997;64-68.
8. Kawauchi S., Fukuda T., Tsuneyoshi M. Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas. Oncol Rep. 6:1999;959-964.
9. Kim K.J., Li B., Winer J., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841-844.
10. Linder C., Linder S., Munck-Wikland E., Strander H. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. Anticancer Res. 18:1998;2063-2068.
11. Enzinger F.M., Weiss S.W. Soft tissue tumors. 1983;CV Mosby, St Louis.
12. UICC: TNM Classification of malignant tumours, 4th ed. Berlin: Springer-Verlag, 1987;85-92.
13. Coindre J.M., Bui N.B., Bonichon F., Mascarel I., Trojani M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer. 61:1988;2305-2309.
14. Kuhnen C., Lehnhardt M., Tolnay E., Muehlberger T., Vogt P.M., Muller K.M. Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours. J Cancer Res Clin Oncol. 126:2000;219-225.
15. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
16. Ohta Y., Watanabe Y., Murakami S., et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer. 76:1997;1041-1045.
17. Saenz N.C., Heslin M.J., Adsay V., et al. Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas. Ann Surg Oncol. 5:1998;48-53.
18. Graeven U., Andre N., Achilles E., Zornig C., Schmiegel W. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma. J Cancer Res Clin Oncol. 125:1999;577-581.
19. Potter D.A., Kinsella T., Glatstein E., et al. High-grade soft tissue sarcomas of the extremities. Cancer. 58:1986;190-205.
20. Gordon M.S., Hajdu S.I., Bains M.S., Burt M.E. Soft tissue sarcomas of the chest wall. J Thorac Cardiovasc Surg. 101:1991;843-854.